Cargando…

Patients’ perceptions of self-administered dosing to opioid agonist treatment and other changes during the COVID-19 pandemic: a qualitative study

OBJECTIVES: During the COVID-19 pandemic, addiction treatment services received official guidance asking them to limit face-to-face contact with patients and to prescribe opioid agonist treatment (OAT) medication flexibly. With the aim for most patients to receive take-home supplies for self-adminis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Scott, Gemma, Turner, Sophie, Lowry, Natalie, Hodge, Annette, Ashraf, Waniya, McClean, Katie, Kelleher, Mike, Mitcheson, Luke, Marsden, John
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2023
Materias:	Addiction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10032386/ https://www.ncbi.nlm.nih.gov/pubmed/36944465 http://dx.doi.org/10.1136/bmjopen-2022-069857

Ejemplares similares

Experience and response to a randomised controlled trial of extended-release injectable buprenorphine versus sublingual tablet buprenorphine and oral liquid methadone for opioid use disorder: protocol for a mixed-methods evaluation
por: Lowry, Natalie, et al.
Publicado: (2022)

Using routinely collected data to understand and predict adverse outcomes in opioid agonist treatment: Protocol for the Opioid Agonist Treatment Safety (OATS) Study
por: Larney, Sarah, et al.
Publicado: (2018)

Evaluating comparative effectiveness of psychosocial interventions for persons receiving opioid agonist therapy for opioid use disorder: protocol for a systematic review
por: Rice, Danielle B, et al.
Publicado: (2018)

Barriers and facilitators to buprenorphine use for opioid agonist treatment: protocol for a scoping review
por: Leece, Pamela, et al.
Publicado: (2019)

Scoping review protocol: the use of telemedicine in providing opioid agonist treatment and related psychosocial supports
por: Crowley, Des, et al.
Publicado: (2020)

Rates of opioid agonist treatment prescribing in provincial prisons in Ontario, Canada, 2015–2018: a repeated cross-sectional analysis
por: Bodkin, Claire, et al.
Publicado: (2021)

Evaluating the association between urine drug screening frequency and retention in opioid agonist treatment in Ontario, Canada: a retrospective cohort study
por: Morin, Kristen A, et al.
Publicado: (2022)

Comparative effectiveness of urine drug screening strategies alongside opioid agonist treatment in British Columbia, Canada: a population-based observational study protocol
por: Guerra-Alejos, B Carolina, et al.
Publicado: (2023)

Comparing opioid types in the persistence of opioid use following surgical admission: a study protocol for a retrospective observational linkage study comparing tapentadol and oxycodone in Australia
por: Lam, Tina, et al.
Publicado: (2022)

Facilitators of and barriers to buprenorphine initiation for people with opioid use disorder in the emergency department: protocol for a scoping review
por: Bozinoff, Nikki, et al.
Publicado: (2021)

Opioid overdose decedent characteristics during COVID-19
por: Garcia, Gian-Gabriel P., et al.
Publicado: (2022)

Primary care management of Long-Term opioid therapy
por: Coffin, Phillip O., et al.
Publicado: (2022)

Randomised, pragmatic, waitlist controlled trial of cannabis added to prescription opioid support on opioid dose reduction and pain in adults with chronic non-cancer pain: study protocol
por: Jashinski, Julia, et al.
Publicado: (2022)

Rewarding recovery: the time is now for contingency management for opioid use disorder
por: Proctor, Steven L.
Publicado: (2022)

Allostatic load in opioid use disorder: a scoping review protocol
por: Fan, Jaimie Qiuyun, et al.
Publicado: (2023)

Epidemiological trends in opioid-only and opioid/polysubstance-related death rates among American Indian/Alaska Native populations from 1999 to 2019: a retrospective longitudinal ecological study
por: Qeadan, Fares, et al.
Publicado: (2022)

Slow release oral morphine versus methadone for the treatment of opioid use disorder
por: Klimas, Jan, et al.
Publicado: (2019)

Quality of life and relapse of Opioid Use Disorder: a scoping review protocol
por: Namatovu, Angella, et al.
Publicado: (2023)

Measurement‐based care using DSM‐5 for opioid use disorder: can we make opioid medication treatment more effective?
por: Marsden, John, et al.
Publicado: (2019)

Opioid substitution therapy as a strategy to reduce deaths in prison: retrospective cohort study
por: Larney, Sarah, et al.
Publicado: (2014)

Contingency management for tobacco smoking during opioid addiction treatment: a randomised pilot study
por: Ainscough, Tom Stephen, et al.
Publicado: (2017)

Opioid use disorder in chronic non-cancer pain in Germany: a cross sectional study
por: Just, Johannes Maximilian, et al.
Publicado: (2019)

U.S. Military veterans and the opioid overdose crisis: a review of risk factors and prevention efforts
por: Bennett, Alex S., et al.
Publicado: (2022)

Opioid use and harms associated with a sustained-release tapentadol formulation: a postmarketing study protocol
por: Peacock, Amy, et al.
Publicado: (2018)

What are the characteristics of vitamin D metabolism in opioid dependence? An exploratory longitudinal study in Australian primary care
por: Reece, Albert Stuart, et al.
Publicado: (2018)

Risk of behaviour suggestive of opioid abuse: a protocol for a systematic review of validated assessment tools
por: Galindo, Sheila Raposo, et al.
Publicado: (2018)

The changing epidemiology of opioid overdose in Baltimore, Maryland, 2012–2017: insights from emergency medical services
por: Dun, Chen, et al.
Publicado: (2022)

Prior authorization restrictions on medications for opioid use disorder: trends in state laws from 2005 to 2019
por: Andraka-Christou, Barbara, et al.
Publicado: (2023)

Interest in treatment with injectable diacetylmorphine among people who use opioids in Baltimore City, Maryland (USA)
por: Allen, Sean T., et al.
Publicado: (2023)

From pain treatment to opioid dependence: a qualitative study of the environmental influence on codeine use in UK adults
por: Kinnaird, Emma, et al.
Publicado: (2019)

Mixed-methods study to examine the response of opioid addiction treatment programmes to COVID-19: a study protocol
por: Choi, Sugy, et al.
Publicado: (2022)

Perceptions of COVID-19 risk during the pandemic: perspectives from people seeking medication for opioid use disorder
por: Clingan, Sarah E., et al.
Publicado: (2023)

Prescription opioid injection and risk of hepatitis C in relation to traditional drugs of misuse in a prospective cohort of street youth
por: Hadland, Scott E, et al.
Publicado: (2014)

Reducing the default dispense quantity for new opioid analgesic prescriptions: study protocol for a cluster randomised controlled trial
por: Bachhuber, Marcus A, et al.
Publicado: (2018)

Opioid maintenance treatment in the Czech Republic, Norway and Denmark: a study protocol of a comparative registry linkage study
por: Gabrhelík, Roman, et al.
Publicado: (2021)

Strengthening systems of care for people with or at risk for HIV, HCV and opioid use disorder: a call for enhanced data collection
por: Eller, Anthony J., et al.
Publicado: (2022)

Protocol for a mixed-methods feasibility study for the surviving opioid overdose with naloxone education and resuscitation (SOONER) randomised control trial
por: Orkin, Aaron, et al.
Publicado: (2019)

Opioid analgesic use after ambulatory surgery: a descriptive prospective cohort study of factors associated with quantities prescribed and consumed
por: Shanahan, Christopher W, et al.
Publicado: (2021)

Dynamic changes in methadone utilisation for opioid use disorder treatment: a retrospective observational study during the COVID-19 pandemic
por: Kennalley, Amy L, et al.
Publicado: (2023)

Open-label dose-extending placebos for opioid use disorder: a protocol for a randomised controlled clinical trial with methadone treatment
por: Belcher, Annabelle M, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_mrnt6bsnumi29fjk59ikcbcqrm